Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.

Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR; Guthy-Jackson Charitable Foundation International Clinical Consortium (GJCF–ICC).

Neurol Neuroimmunol Neuroinflamm. 2019 Jun 28;6(5). pii: e583. doi: 10.1212/NXI.0000000000000583. Print 2019 Sep.

2.

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.

Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR; Guthy-Jackson Charitable Foundation International Clinical Consortium (GJCF–ICC).

Neurol Neuroimmunol Neuroinflamm. 2019 Jun 28;6(5):e583. doi: 10.1212/NXI.0000000000000583. eCollection 2019 Sep.

3.

Breast Hormone Concentrations in Random Fine-Needle Aspirates of Healthy Women Associate with Cytological Atypia and Gene Methylation.

Lee O, Heinz RE, Ivancic D, Muzzio M, Chatterton RT, Zalles CM, Keeney K, Phan B, Liu D, Scholtens D, Fackler MJ, Stearns V, Sukumar S, Khan SA.

Cancer Prev Res (Phila). 2018 Sep;11(9):557-568. doi: 10.1158/1940-6207.CAPR-17-0323. Epub 2018 Jun 28.

4.

Nanofibrous PLGA electrospun scaffolds modified with type I collagen influence hepatocyte function and support viability in vitro.

Brown JH, Das P, DiVito MD, Ivancic D, Tan LP, Wertheim JA.

Acta Biomater. 2018 Jun;73:217-227. doi: 10.1016/j.actbio.2018.02.009. Epub 2018 Feb 15.

5.

Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.

Wang J, Shidfar A, Ivancic D, Ranjan M, Liu L, Choi MR, Parimi V, Gursel DB, Sullivan ME, Najor MS, Abukhdeir AM, Scholtens D, Khan SA.

Int J Cancer. 2017 Jun 1;140(11):2484-2497. doi: 10.1002/ijc.30680. Epub 2017 Mar 21.

6.

Expression of miR-18a and miR-210 in Normal Breast Tissue as Candidate Biomarkers of Breast Cancer Risk.

Shidfar A, Costa FF, Scholtens D, Bischof JM, Sullivan ME, Ivancic DZ, Vanin EF, Soares MB, Wang J, Khan SA.

Cancer Prev Res (Phila). 2017 Jan;10(1):89-97. doi: 10.1158/1940-6207.CAPR-16-0177. Epub 2016 Oct 27.

7.

Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk.

Stearns V, Fackler MJ, Hafeez S, Bujanda ZL, Chatterton RT, Jacobs LK, Khouri NF, Ivancic D, Kenney K, Shehata C, Jeter SC, Wolfman JA, Zalles CM, Huang P, Khan SA, Sukumar S.

Cancer Prev Res (Phila). 2016 Aug;9(8):673-682. doi: 10.1158/1940-6207.CAPR-15-0377. Epub 2016 Jun 3.

8.

Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes.

Clare SE, Gupta A, Choi M, Ranjan M, Lee O, Wang J, Ivancic DZ, Kim JJ, Khan SA.

BMC Cancer. 2016 May 23;16:326. doi: 10.1186/s12885-016-2355-5.

9.

Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid.

Shidfar A, Fatokun T, Ivancic D, Chatterton RT, Khan SA, Wang J.

Horm Cancer. 2016 Aug;7(4):252-9. doi: 10.1007/s12672-016-0264-3. Epub 2016 Apr 19.

PMID:
27094399
10.

Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.

Lee O, Choi MR, Christov K, Ivancic D, Khan SA.

Cancer Lett. 2016 Jul 1;376(2):310-7. doi: 10.1016/j.canlet.2016.04.010. Epub 2016 Apr 11.

PMID:
27080304
11.

Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk.

Chatterton RT, Heinz RE, Fought AJ, Ivancic D, Shappell C, Allu S, Gapstur S, Scholtens DM, Gann PH, Khan SA.

Horm Cancer. 2016 Apr;7(2):127-36. doi: 10.1007/s12672-016-0252-7. Epub 2016 Feb 22.

12.

Cytologic atypia in the contralateral unaffected breast is related to parity and estrogen-related genes.

Monahan DA, Wang J, Lee O, Revesz E, Taft N, Ivancic D, Hansen NM, Bethke KP, Zalles C, Khan SA.

Surg Oncol. 2016 Dec;25(4):449-456. doi: 10.1016/j.suronc.2015.12.001. Epub 2015 Dec 30.

PMID:
26856771
13.

Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation.

Lee O, Ivancic D, Allu S, Shidfar A, Kenney K, Helenowski I, Sullivan ME, Muzzio M, Scholtens D, Chatterton RT Jr, Bethke KP, Hansen NM, Khan SA.

Cancer Chemother Pharmacol. 2015 Dec;76(6):1235-46. doi: 10.1007/s00280-015-2848-y. Epub 2015 Nov 11.

PMID:
26560487
14.

A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.

Lee O, Page K, Ivancic D, Helenowski I, Parini V, Sullivan ME, Margenthaler JA, Chatterton RT Jr, Jovanovic B, Dunn BK, Heckman-Stoddard BM, Foster K, Muzzio M, Shklovskaya J, Skripkauskas S, Kulesza P, Green D, Hansen NM, Bethke KP, Jeruss JS, Bergan R, Khan SA.

Clin Cancer Res. 2014 Jul 15;20(14):3672-82. doi: 10.1158/1078-0432.CCR-13-3045.

15.

RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.

Hu H, Wang J, Gupta A, Shidfar A, Branstetter D, Lee O, Ivancic D, Sullivan M, Chatterton RT Jr, Dougall WC, Khan SA.

Breast Cancer Res Treat. 2014 Aug;146(3):515-23. doi: 10.1007/s10549-014-3049-9. Epub 2014 Jul 10.

PMID:
25007964
16.

Lipid metabolism genes in contralateral unaffected breast and estrogen receptor status of breast cancer.

Wang J, Scholtens D, Holko M, Ivancic D, Lee O, Hu H, Chatterton RT Jr, Sullivan ME, Hansen N, Bethke K, Zalles CM, Khan SA.

Cancer Prev Res (Phila). 2013 Apr;6(4):321-30. doi: 10.1158/1940-6207.CAPR-12-0304. Epub 2013 Mar 19.

17.

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen NM, Bethke KP, Dew A, Coomes M, Bergan RC.

Cancer Prev Res (Phila). 2012 Feb;5(2):309-19. doi: 10.1158/1940-6207.CAPR-11-0251.

18.

In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast.

Lee O, Ivancic D, Chatterton RT Jr, Rademaker AW, Khan SA.

Breast Cancer (Dove Med Press). 2011 Jul 14;3:61-70. doi: 10.2147/BCTT.S20821. eCollection 2011.

19.

Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations.

Chatterton RT Jr, Khan SA, Heinz R, Ivancic D, Lee O.

Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):275-9. doi: 10.1158/1055-9965.EPI-09-0381.

20.

Epithelial NF-kappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation.

Tang Y, Clayburgh DR, Mittal N, Goretsky T, Dirisina R, Zhang Z, Kron M, Ivancic D, Katzman RB, Grimm G, Lee G, Fryer J, Nusrat A, Turner JR, Barrett TA.

Am J Pathol. 2010 Jan;176(1):158-67. doi: 10.2353/ajpath.2010.090548. Epub 2009 Dec 11.

21.

Ductal lavage is an inefficient method of biomarker measurement in high-risk women.

Khan SA, Lankes HA, Patil DB, Bryk M, Hou N, Ivancic D, Nayar R, Masood S, Rademaker A.

Cancer Prev Res (Phila). 2009 Mar;2(3):265-73. doi: 10.1158/1940-6207.CAPR-08-0119. Epub 2009 Feb 17.

22.

Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.

Cohen JA, Calabresi PA, Chakraborty S, Edwards KR, Eickenhorst T, Felton WL 3rd, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Imrey PB, Ivancic DM, Mandell BF, Perryman JE, Scott TF, Skaramagas TT, Zhang H; ACT Investigators.

Mult Scler. 2008 Apr;14(3):370-82. doi: 10.1177/1352458507083189. Epub 2008 Jan 21.

PMID:
18208877
23.

Tissue-specific transcripts of human steroid sulfatase are under control of estrogen signaling pathways in breast carcinoma.

Zaichuk T, Ivancic D, Scholtens D, Schiller C, Khan SA.

J Steroid Biochem Mol Biol. 2007 Jun-Jul;105(1-5):76-84. Epub 2007 May 16.

PMID:
17596930
24.

Cataract surgery and postoperative complications in diabetic patients.

Ivancić D, Mandić Z, Barać J, Kopić M.

Coll Antropol. 2005;29 Suppl 1:55-8.

PMID:
16193678
25.

Effect of intraocular silicone oil on ocular tissue.

Barać J, Katusić D, Ivancić D, Sisljagić V, Bradvica M.

Coll Antropol. 2005;29 Suppl 1:51-4.

PMID:
16193677
26.

IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection.

Zhang Z, Kaptanoglu L, Tang Y, Ivancic D, Rao SM, Luster A, Barrett TA, Fryer J.

Gastroenterology. 2004 Mar;126(3):809-18.

PMID:
14988835
27.

Differential effects of T-cell activation on gastric and small bowel permeability in alcohol-consuming mice.

Alnadjim Z, Kayali Z, Haddad W, Holmes EW, Keshavarzian A, Mittal N, Ivancic D, Koehler R, Goldsmith D, Waltenbaugh C, Barrett TA.

Alcohol Clin Exp Res. 2002 Sep;26(9):1436-43.

PMID:
12351940
28.

Single vs. dual vessel porcine extracorporeal liver perfusion.

Mora N, Kaptanoglu L, Zhang Z, Niekrasz M, Black S, Ver Steeg K, Wade R, Siddall V, Pao W, Walsh W, Ivancic D, Kaufman D, Abecassis M, Stuart F, Blei A, Leventhal J, Fryer J.

J Surg Res. 2002 Apr;103(2):228-35.

PMID:
11922739
29.

Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism.

Zhang Z, Kaptanoglu L, Haddad W, Ivancic D, Alnadjim Z, Hurst S, Tishler D, Luster AD, Barrett TA, Fryer J.

J Immunol. 2002 Apr 1;168(7):3205-12.

30.

Distribution of, and immune response to, chicken anti-alpha Gal immunoglobulin Y antibodies in wild-type and alpha Gal knockout mice.

Walsh WE Jr, Anderson BE, Ivancic D, Zhang Z, Piccini JP, Rodgers TG, Pao W, Fryer JP.

Immunology. 2000 Dec;101(4):467-73.

31.

Synthetic peptides which inhibit the interaction between C1q and immunoglobulin and prolong xenograft survival.

Fryer JP, Leventhal JR, Pao W, Stadler C, Jones M, Walsh T, Zhong R, Zhang Z, Wang H, Goodman DJ, Kurek M, d'Apice AJ, Blondin B, Ivancic D, Buckingham F, Kaufman D, Abecassis M, Stuart F, Anderson BE.

Transplantation. 2000 Sep 15;70(5):828-36.

PMID:
11003366
32.

IgY antiporcine endothelial cell antibodies effectively block human antiporcine xenoantibody binding.

Fryer J, Firca J, Leventhal J, Blondin B, Malcolm A, Ivancic D, Gandhi R, Shah A, Pao W, Abecassis M, Kaufman D, Stuart F, Anderson B.

Xenotransplantation. 1999 May;6(2):98-109.

PMID:
10431786
33.

Inhibition of human serum mediated lysis of porcine endothelial cells using a novel peptide which blocks C1Q binding to xenoantibody.

Fryer JP, Blondin B, Stadler C, Ivancic D, Rattner U, Kaplan B, Kaufman D, Abecassis M, Stuart F, Anderson B.

Transplant Proc. 1997 Feb-Mar;29(1-2):883. No abstract available.

PMID:
9123567
34.

Early histopathology of small intestinal discordant xenografts.

Yedidag EN, Fryer JP, Levi E, Buckingham FC, Ivancic D, Kraff J, Huang CF, Rademaker AW, Kaufman DB, Abecassis M, Stuart FP.

Transplantation. 1996 Nov 27;62(10):1385-91.

PMID:
8958261

Supplemental Content

Loading ...
Support Center